NLRP3 and depressive symptom measurement: Inhibiting the NLRP3 inflammasome also led to decreased mitochondrial reactive oxygen species (mtROS) accumulation and increased mitophagy in vitro, ultimately increasing the clearance of damaged mitochondria in the studied models of depression.